Scarica l'app Stockscreener
3.44
4.18%
-0.15
Dopo l'orario di chiusura:
3.21
-0.23
-6.69%
Precedente Chiudi:
$3.59
Aprire:
$3.25
Volume 24 ore:
489.55K
Relative Volume:
2.13
Capitalizzazione di mercato:
$1.87M
Reddito:
-
Utile/perdita netta:
$-16.72M
Rapporto P/E:
-0.0537
EPS:
-64.0349
Flusso di cassa netto:
$-12.29M
1 W Prestazione:
+17.81%
1M Prestazione:
-44.78%
6M Prestazione:
-58.84%
1 anno Prestazione:
-88.62%
Intervallo 1D:
$3.0198
$3.88
Intervallo di 1 settimana:
$2.44
$7.25
Portata 52W:
$2.44
$32.55
Autonomix Medical Inc Stock (AMIX) Company Profile
Nome
Autonomix Medical Inc
Settore
Industria
Telefono
832-277-7816
Indirizzo
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
3.44 | 1.51M | 0 | -16.72M | -12.29M | -64.03 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Autonomix Medical Inc Borsa (AMIX) Ultime notizie
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
Autonomix Medical Inc (AMIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AMIX|Autonomix Medical Inc|Price:2.920|Chg%:-0.580 - TradingKey
Autonomix Medical Inc (AMIX) Balance Sheet - TradingKey
AMIX|Autonomix Medical Inc|Price:2.755|Chg%:-0.165 - TradingKey
Autonomix Medical Inc. (AMIX) Plunges Over 16% – Key Support Levels Under PressureInvestment Factor - dars.gov.et
TradingKey - TradingKey
AMIX|Autonomix Medical Inc|Price:2.900|Chg%:-0.600 - TradingKey
AMIX Drops As Warrant Inducement Raises Dilution Fears - StocksToTrade
Autonomix Medical, Inc. (AMIX) stock price, news, quote and history - Yahoo Finance UK
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study - marketscreener.com
Autonomix reports preclinical data on renal nerve sensing tech - Investing.com
Autonomix reports preclinical data on renal nerve sensing tech By Investing.com - Investing.com Canada
Autonomix Medical Reports Preclinical Study Shows Neural Sensing Platform Can Detect and Localize Renal Nerve Activity - Quiver Quantitative
In an animal study, Autonomix catheter detected kidney nerve changes - Stock Titan
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Autonomix Medical Secures New US Patent Strengthening Next-Generation Precision Neuromodulation Platform - TradingView
Autonomix Medical receives patent for nervous system assessment tech - Investing.com
New Autonomix patent covers nerve-signal monitoring during treatment - Stock Titan
Frontier tech research, news & data - MLQ.ai
Autonomix Medical (AMIX) Proxy filing Summary - Quartr
Autonomix Medical (AMIX) Registration filing Summary - Quartr
Autonomix Medical, Inc. Common Stock (NASDAQ: AMIX) Share Price, AMIX Stock News, AMIX Share Price & Updates - Kalkine
Autonomix Medical raises up to $2.6M through warrant inducement - MSN
Autonomix Medical (AMIX) Retreats to $5.02 as Support Level TestedFear Greed Index - dars.gov.et
Autonomix Medical (AMIX) Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Cash Burn for Clinical-Stage Device FirmEarnings Risk Report - dars.gov.et
Autonomix Medical Announces $2.6 Million At-the-Market Warrant Inducement Agreement to Accelerate Growth - Minichart
Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants - TradingView
Autonomix granted U.S. patent for overactive bladder diagnosis - TipRanks
Autonomix Medical receives patent for overactive bladder device - Investing.com UK
Autonomix Medical receives patent for overactive bladder device By Investing.com - Investing.com Nigeria
Autonomix Medical Receives U.S. Patent Expanding Neural Sensing Platform Into Overactive Bladder Urology Market - Moomoo
Autonomix Medical Receives U.S. Patent Expanding Neural Sensing Platform into Overactive Bladder Urology Market - Quiver Quantitative
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform - GlobeNewswire
Autonomix Patent Covers Catheter That Maps and Treats Bladder Nerves - Stock Titan
Investor Agrees to Exercise 428,731 Autonomix Warrants - Stock Titan
Autonomix enters into $2.6M warrant inducement priced at $6.00 - TipRanks
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules - marketscreener.com
Autonomix Medical wins new patent for neural sensing technology - Proactive financial news
symbol__ Stock Quote Price and Forecast - CNN
Autonomix granted Canadian patent for neural sensing - TipRanks
Autonomix Medical Announces Canadian Patent Grant Strengthening Its Real-Time Nerve Sensing and Denervation IP Portfolio - Quiver Quantitative
Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant - GlobeNewswire
Autonomix Medical Inc. (AMIX) Slips 12.48% as Shares Test Key Support LevelsDealer Gamma - dars.gov.et
Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status - The Globe and Mail
Autonomix Medical, Inc. 8-K Filing: NASDAQ Compliance Update and Company Details (July 2026) - Minichart
Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak - TradingView
Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance - Stock Titan
Autonomix Medical (AMIX) Slips 1.58% as Stock Tests Key Support ZoneElliott Wave Count - dars.gov.et
AMIX Q2 2026 Earnings: Loss Narrows as Clinical Progress Offsets Cautious OutlookROIC Trend Report - dars.gov.et
Autonomix Medical Inc Azioni (AMIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):